AMBEST PHARMACEUTICAL (CHINA)
Ambest Pharmaceutical (China) is engaged in the manufacturing of large volume injectables, and research, technology transfer and technology services of pharmaceutical products. It currently holds the drug production approvals of monoammonium glycyrrhizinate and cysteine and sodium chloride injection and floium Ginkgo extract and tertram rthypyrazine sodium chloride injection.
AMBEST PHARMACEUTICAL (CHINA)
Industry:
Biotechnology Manufacturing Pharmaceutical
Address:
Beijing, Beijing, China
Country:
China
Status:
Active
Similar Organizations
Ambee
Ambee manufactures a pharmaceutical products.
Aspire India
Aspire India manufactures pharmaceutical equipment.
Braintree Laboratories
Braintree Laboratories manufactures pharmaceutical products.
Huaren Pharmaceutical
Huaren Pharmaceutical manufactures pharmaceutical products.
Kanghui Pharmaceutical
Shaanxi Kanghui Pharmaceutical manufactures pharmaceutical products.
Lee Pharma
Lee Pharma manufactures pharmaceutical products.
Scott-Edil Pharmacia
Scott-Edil Pharmacia manufactures pharmaceutical products.
The Arab Pharmaceutical Manufacturing Co. Ltd.
The Arab Pharmaceutical Manufacturing Co. Ltd. manufactures pharmaceutical products.
More informations about "Ambest Pharmaceutical (China)"
Ambest Pharmaceutical (China) - Crunchbase
Ambest Pharmaceutical (China) is engaged in the manufacturing of large volume injectables, and research, technology transfer and technology services of pharmaceutical products. It currently โฆSee details»
Ambest Pharmaceutical (China) - Drug pipelines, Patents, Clinical ...
Jan 23, 2025 Explore Ambest Pharmaceutical (China) with its drug pipeline, therapeutic area, technology platform, . ... Explore the financial positions of over 360K organizations with โฆSee details»
Ambest Pharmaceutical (China) Company - PitchBook
Ambest Pharmaceutical (China) Company General Information Description. Manufacturer of pharmaceutical products. The company's pharmaceutical products include injections, cysteine โฆSee details»
Ambest Pharmaceutical (China) Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ambest Pharmaceutical (China) Co., Ltd. of Meihekou, Jilin. Get the latest business insights from Dun โฆSee details»
Ambest Pharma - Products, Competitors, Financials, Employees ...
Ambest Pharmaceutical is engaged in the manufacturing of large volume injections, and research, technology transfer and technology services of pharmaceutical products. Use the CB Insights โฆSee details»
Ambest Pharmaceutical (China) (Ambest Pharmaceutical (China))
ไบ่งฃAmbest Pharmaceutical (China) (Ambest Pharmaceutical (China))ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็ใSee details»
Ambest Pharmaceutical Co. Ltd. - Drug pipelines, Patents, Clinical ...
Mar 9, 2025 Explore Ambest Pharmaceutical Co. Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Sihuan Pharmaceutical Acquires Ambest Pharma China For $160
Mar 24, 2017 Since its $742 million Hong Kong IPO in 2010, Sihuan has been an active participant in China pharma M&A while also developing a robust R&D pipeline. The company โฆSee details»
Sihuan Pharmaceutical acquires Ambest Pharmaceutical (China)
Sihuan Pharmaceutical acquires Ambest Pharmaceutical (China) on 2017-03-27 for $160082661. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. โฆSee details»
Ambest Pharmaceutical China, Meihekou | Info-clipper.com
Reports on Ambest Pharmaceutical (China) Co., Ltd. include information such as : Ambest Pharmaceutical (China) Co., Ltd. is headquartered in Meihekou : The Business report also list โฆSee details»
Sihuan Pharma Acquires Ambest Pharma China for $160 Million
Mar 23, 2017 Sihuan Pharma, headquartered in Beijing, will pay $160 million to acquire Ambest Pharma of China, a maker of large volume injection products. Ambest offers saline (sodium โฆSee details»
Sihuan Pharma to acquire fellow Chinese drug firm
Mar 27, 2017 Chinaโs Sihuan Pharmaceutical says that its wholly-owned subsidiary Sun Moral International (HK) has entered into an equity acquisition agreement with Ambest โฆSee details»
M&As this week: Sun Moral International (HK), Immuno Holding
Mar 23, 2017 Sun Moral International (HK), a subsidiary of Chinese pharmaceutical company Sihuan Pharmaceutical Holdings Group, has acquired the entire equity interest in Ambest โฆSee details»
Ambest Pharmaceutical (China) - Crunchbase
Organization. Ambest Pharmaceutical (China) Connect to CRM . Save . Summary People Signals & News Similar Companies. Similar Companies. Edit Similar Companies Section. Companies โฆSee details»
China's Pharma Giants: Top 10 Biggest Pharmaceutical
Sep 22, 2023 Sinopharm is a giant in Chinaโs pharmaceutical landscape, boasting revenues upwards of $40 billion. Founded in 2003, it has quickly grown to become a leader in โฆSee details»
Trump tariffs drive pharma manufacture to US but risk inflation โฆ
On 4 March 2025, Trump imposed tariffs on most imports from Canada, Mexico and China, set at 25% for Canada and Mexico, and doubled on China from 10% to 20%. These could come into โฆSee details»
Sihuan Pharmaceutical Acquires Ambest Pharma China For $160
Mar 24, 2017 Since its $742 million Hong Kong IPO in 2010, Sihuan has been an active participant in China pharma M&A while also developing a robust R&D pipeline. The company โฆSee details»
Beijing Aohe Pharmaceutical Research Institute Co., Ltd. et al v ...
AMBEST PHARMACEUTICAL COMPANY LTD et al of '293 (Decision - 288881) from Commission 1F344534, , the decision made on 01/04/2022 Chinese Re-examination case โฆSee details»
Full List of Biotech and Pharmaceutical Companies in China (2024)
Sep 18, 2023 Chna is also the second largest pharmaceutical market after the United States. It holds 12% of the global pharma market, generating 708.75 billion yuan in 2021. The local โฆSee details»
5 Chinese pharma companies sign on to make generic version of โฆ
Mar 18, 2022 Five pharmaceutical companies in China have signed on with UN-backed public health organization Medicines Patent Pool (MPP) to manufacture the generic version of โฆSee details»